EC Mergers & Acquisitions
EC M&A provides investment banking and financial advisory, buy-side acquisition, cross-border, divestiture, and capital-raising services. Its stated focus is middle-market transactions across industrial and life-science technologies.
What stands out about EC Mergers & Acquisitions
EC M&A publicly positions itself as a middle-market M&A advisor serving industrial-technology and life-science businesses across the United States, Europe, South America, and Asia. Its disclosed work includes buy-side acquisitions, corporate divestitures, sales of non-core assets, capital raises, and cross-border transactions.[1][2][5][6]
What does EC Mergers & Acquisitions do?
EC Mergers & Acquisitions, branded EC M&A, is an M&A advisory and merchant banking firm focused on industrial technology, life-science technology, and related sectors.
The official site identifies the firm’s headquarters as 885 Third Avenue, 34th Floor, New York, NY 10022, United States. EC M&A states that it advises across the United States, Europe, South America, and Asia, with offices listed in New York, Chicago, Los Angeles, São Paulo, London, Frankfurt, Paris, Hong Kong, and Beijing.[1]
EC M&A publicly states that it provides investment banking and financial advisory, mergers and acquisitions, proactive buy-side acquisition services, cross-border transactions, corporate divestitures and sales of non-core assets, and capital raises.
Its stated transaction role includes advising on complex transactions. The cited official transactions page does not publish a standard fee schedule, success-fee percentage, minimum fee, tail period, or termination schedule.[2][5]
Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.
What should a business owner evaluate before hiring EC Mergers & Acquisitions?
Owners of industrial-technology or life-science businesses can evaluate EC M&A against its disclosed middle-market orientation, sector coverage, cross-border activity, and examples of sell-side and corporate-transaction work.
Before appointing the advisor, an owner should confirm which legal entity would sign the engagement and provide the services; the applicable transaction-size, revenue, EBITDA, and geography parameters; comparable recent assignments; buyer-universe development and conflict checks; the team responsible for the mandate; and the fee, expense, exclusivity, tail, termination, indemnity, and timing provisions.[1][2][3][5]
Which legal entity would sign the engagement and provide the services
What transaction-size, revenue, EBITDA, or geography thresholds apply to a new mandate
Which recent transactions share the prospective mandate’s sector, scale, or ownership characteristics
What size transactions and clients does EC Mergers & Acquisitions focus on?
EC M&A identifies industrial technologies and life sciences and medical technologies as its principal sector areas.
Its industrial-technology coverage includes test and measurement, gas analysis and monitoring, Industry 4.0/IIoT, water and wastewater, pumps and valves, non-destructive testing and metrology, specialty chemicals, optics and photonics, semiconductor equipment and components, PPE and safety/security, energy, and transportation/aerospace.
Within test and measurement, the firm states that its focus includes instruments, instrumentation components and subsystems, sensors, consumables and reagents, testing and analysis services, and software.[3][4]
The official transaction archive identifies examples including Perimeter Solutions’ acquisition of Monaco Enterprises; TriOS’ sale to Xylem; Sutter Instrument’s sale to Lafayette Instrument; Halma’s sale of Cardios to Cardioline; and LDC’s sale of Mi Hub to Sullivan Street Partners.
On a dedicated transaction page, EC M&A states that it acted as exclusive financial adviser to Sutter Instrument in its sale to Lafayette Instrument, a portfolio company of Branford Castle Partners.[5][6]
The official transactions page states that EC M&A focuses on middle-market transactions across industrial and life-science technologies. Publicly stated services cover acquisitions, buy-side programs, corporate divestitures, sales of non-core assets, cross-border transactions, and capital raises.
EC M&A also states that 90% of the companies it buys for clients are non-auction bilateral transactions. It states that more than 70% of its transactions involve a seller in one country and a buyer in another.[1][2][5][10]
What does EC Mergers & Acquisitions publicly disclose about fees, process and engagement terms?
The cited official transactions page does not publish quantitative revenue, EBITDA, enterprise-value, or minimum and maximum transaction-size thresholds. It also does not publish a standard fee schedule, success-fee percentage, minimum fee, tail period, or termination schedule.
The cited official services page does not state a universal owner-company revenue, EBITDA, enterprise-value, or transaction-size eligibility rule for new engagements.
The cited official Sutter Instrument transaction page does not disclose the transaction value, consideration structure, or fee terms.[2][5][6]
The EC M&A site states that U.S. securities are offered through EuroConsult Capital LLC, a EuroConsult subsidiary described as a broker-dealer and FINRA member.
FINRA’s organization-level firm report identifies EuroConsult Capital, LLC as CRD #143366 and SEC #8-67554. An SEC-filed 2025 annual audit describes the entity as a securities broker-dealer engaged in investment banking, including private placements and mergers and acquisitions.
The FCA identifies EuroConsult International Mergers & Acquisitions Limited as the genuine authorized firm associated with the EC M&A website and lists Firm Reference Number 462010.[5][7][8][9]
EC M&A states that 90% of the companies it buys for clients are non-auction bilateral transactions. It also states that more than 70% of its transactions involve a seller in one country and a buyer in another.
These statements describe the firm’s publicly stated buy-side and cross-border activity. They do not establish a universal process, timeline, fee structure, or engagement term for every mandate.[1][5][10]
Questions to ask before hiring EC Mergers & Acquisitions
Which legal entity would sign the engagement and provide the services?
What transaction-size, revenue, EBITDA, or geography thresholds apply to a new mandate?
Which recent transactions share the prospective mandate’s sector, scale, or ownership characteristics?
How is the buyer universe developed and how are conflicts checked across strategic, private-equity, family-office, and venture-arm relationships?
What are the retainer, success-fee formula, expense reimbursement, exclusivity, tail, termination, and indemnity provisions?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Industry / market focus
- Industry focus
- Transaction size / criteria
- Transaction / portfolio evidence
- FINRA regulatory record
- SEC filing / regulatory record
- Structure / regulatory context
- Public Process
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.